Related Experiment Video
Updated: Apr 26, 2026

Upper-extremity Approach for Secondary Access in Transfemoral Transcatheter Aortic Valve Implantation
Published on: August 8, 2025
Antithrombotic therapy before, during and after transcatheter aortic valve replacement (TAVR)
Abhishek Sharma1, Sunny Goel, Carl J Lavie
1Division of Cardiovascular Medicine, State University of New York Downstate Medical Center, 1016, 50th Street, Apt 2C, Brooklyn, NY, 11219-9997, USA, abhisheksharma4mamc@gmail.com.
Abstract:
Transcatheter aortic valve replacement (TAVR) has been emerged as a promising alternative for the management of patients with severe AS who otherwise are deemed inappropriate candidates for surgery. Post procedural thromboembolic events and risk of bleeding continue to be a significant challenge in managing patients who underwent TAVR. This article systematically reviews the evidence, current guidelines and upcoming studies investigating antithrombotic therapy before, during and after TAVR.
More Related Videos
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Aortic Regurgitation III: Medical Management
Aneurysm IV: Nursing Management
Coronary Artery Disease V: Interprofessional Care
Acute Coronary Syndrome IV: Interprofessional Care

